Lumira Ventures joins HistoSonics' $54 mln Series C round
HistoSonics, an Ann Arbor, Michigan-based medical device company, has raised US$54 million in a Series C financing. The round was led by Varian Medical Systems Inc and joined by new and existing investors, including Lumira Ventures, a Canadian life sciences venture capital firm. Founded in 2009, HistoSonics has created a non-invasive robotic platform and novel beam therapy that destroys targeted tissues, including diseased tissues and tumors. The round's proceeds will be used to complete regulatory and commercial milestones and further develop the technology.
12 April 2019•4 mins read
